Corona Remedies IPO Allotment Out – Check Bigshare Status

The Verdict Is In for Pharma Investors

The wait is finally over for millions of anxious investors. In a financial event that has captured the attention of market watchers from New York to New Delhi, the Corona Remedies IPO allotment status has been finalized today, Thursday, December 11, 2025.

For the past three days, the global investment community has watched with bated breath as the Indian pharmaceutical sector delivered yet another blockbuster. With the issue oversubscribed by a massive 137 times, the scramble for shares has created a pressure cooker environment. Billions of rupees are currently locked in the banking system, and thousands of retail investors are refreshing their screens, asking the same question: “Did I get the allotment?”

This isn’t just about a stock listing; it is a litmus test for the global appetite for emerging market healthcare assets. Whether you are a U.S.-based institutional investor tracking emerging markets or a retail applicant hoping for listing gains, today is the day of reckoning.

If you are looking for the definitive guide on how to check your Corona Remedies IPO allotment, understand the role of Bigshare Services, and predict the listing gains based on the latest GMP, you have arrived at the right place.

The Big Picture: Why This IPO Matters Globally

The Corona Remedies IPO is not just a local news story; it is a signal flare for the Business and Finance world. In 2025, the pharmaceutical sector remains a defensive stronghold for portfolios facing economic volatility. Corona Remedies, with its strong foothold in women’s healthcare and cardio-diabetology, represents the kind of “middle-of-the-pyramid” growth story that global funds love.

The Numbers That Shocked the Market

The subscription figures released yesterday were nothing short of historic.

• Qualified Institutional Buyers (QIBs): Subscribed 278.52x. This level of interest from banks and mutual funds—some potentially with foreign capital origins—signals immense confidence.
• Non-Institutional Investors (NIIs): Subscribed 208.88x.
• Retail Investors: Subscribed 28.73x.

For the average investor, this math is brutal. It means that in the retail category, less than 1 in 28 applicants will receive a single share. This scarcity drives the “Grey Market Premium” (GMP) and creates the frenzy we are witnessing today surrounding the Corona Remedies IPO allotment date.

How to Check Corona Remedies IPO Allotment Status on Bigshare

The official registrar for this issue is Bigshare Services Pvt. Ltd. They are the keepers of the list. If you want to know your fate first, this is the most direct source.

Follow this step-by-step guide to check your Bigshare IPO allotment status:

Step 1: Visit the Portal

Navigate to the official Bigshare website. You can find their dedicated IPO status page via a quick search or by visiting their main domain. Ensure you are on the secure version of the site (https).

Step 2: Select the Server

Bigshare often provides 3-4 distinct server links (Server 1, Server 2, etc.) to handle the massive traffic load. If one is slow, immediately switch to another. All servers access the same database.

Step 3: Find the Company

Look for the dropdown menu labeled “Company Selection.” You will see a list of recent IPOs. Scroll down and select “Corona Remedies Limited”.

• Note: If the name does not appear yet, it means the data is still being uploaded. Refresh the page every 15 minutes.

Step 4: Choose Your Identification Method

You can check your status using three different details:

1. Application Number (Found on your acknowledgement slip)
2. Beneficiary ID / DP ID (Your Demat account number)
3. PAN Number (Permanent Account Number – Recommended for international and local investors for ease)

Step 5: Enter Details and Captcha

Type in the number corresponding to your selection. Enter the 6-digit Captcha code accurately.

Step 6: Hit Search

Click the “Search” button.

• Success: You will see a table displaying your name, shares applied for, and shares allotted.
• Failure: It will show “No Record Found” (check your details) or “Allotted: 0”.

Alternative Ways to Check Status (BSE & NSE)

If the Bigshare IPO portal is crashing due to heavy traffic—a common occurrence with trending IPOs—you can use the stock exchange websites. These are robust and often update simultaneously.

Method 1: BSE (Bombay Stock Exchange)

The BSE website is a favorite for its simplicity.

1. Go to the BSE India “Status of Issue Application” page.
2. Under “Issue Type,” select Equity.
3. Under “Issue Name,” select Corona Remedies Limited from the list.
4. Enter your Application Number OR PAN Number.
5. Check the “I am not a robot” box.
6. Click Search.

Method 2: NSE (National Stock Exchange)

The NSE requires a one-time registration, which adds a layer of security.

1. Visit the NSE specialized IPO portal.
2. Log in with your credentials (create an account if you haven’t).
3. Select “Corona Remedies IPO” from the active list.
4. Your verified PAN will automatically fetch the data if mapped correctly.

Understanding the “Bigshare Services” Role

For our international readers, it is crucial to understand who Bigshare Services is. In the U.S., companies like Computershare or Equiniti often manage share registries. In India, Bigshare Services is a leading Registrar and Share Transfer Agent (RTA).

They are the neutral third party responsible for:

• Processing all IPO applications.
• Eliminating technical rejections (e.g., mismatched names).
• Conducting the lottery for the allotment (since the issue was oversubscribed).
• Initiating refunds and share credits.

When you search for “Bigshare IPO allotment”, you are querying their centralized database. If you have issues with your refund or demat credit later, Bigshare Services is the entity you must contact, not the company (Corona Remedies) itself.

Market Sentiment: GMP and Listing Predictions

The “Grey Market” is an unofficial, over-the-counter market where IPO shares are traded before they list on the stock exchange. It is a powerful sentiment indicator.

Current GMP Status

As of today, December 11, the Corona Remedies IPO GMP is hovering around ₹295 to ₹305 per share.

What Does This Mean?

• Issue Price: ₹1,062 (Upper Band)
• Estimated Listing Price: ₹1,062 + ₹295 = ₹1,357
• Expected Gain: ~28%

For a Business and Finance observer, a 28% instant return is significant. It outperforms most annual bond yields in a single day. This high premium is driven by the company’s strong fundamentals and the scarcity of shares caused by the 137x oversubscription.

Disclaimer: GMP is volatile and not an official indicator. Listing prices can be affected by global market trends on the listing day.

Company Deep Dive: Is Corona Remedies a Long-Term Bet?

While many are flipping for a quick profit, wise capital looks at the long term. Why is there such hype around Corona Remedies?

1. Chronic Therapy Focus

Unlike generic pharma companies that rely on low-margin acute drugs, Corona focuses on chronic therapies like cardio-diabetology and women’s health. These are “sticky” segments; once a patient is on a medication, they rarely switch, ensuring recurring revenue.

2. Manufacturing Excellence

The company operates state-of-the-art facilities that are WHO-GMP certified. For worldwide investors, this certification is a badge of trust, signaling that their products meet rigorous international safety standards.

3. Financial Health

The company has shown a robust Compound Annual Growth Rate (CAGR) in revenue and profit. In a volatile 2025 market, investors are flocking to companies with clean balance sheets and visible cash flows.

4. The “India Opportunity”

With supply chains shifting away from China, India is consolidating its position as the “Pharmacy of the World.” Corona Remedies is perfectly positioned to ride this macro-economic wave, making it a darling for those hunting for Bigshare IPO success stories.

What to Do If You Didn’t Get An Allotment

Given the 28x retail subscription, most applicants will face disappointment today. If the Bigshare IPO status shows “Not Allotted,” here is your game plan:

1. Wait for Refunds: The refund process begins tomorrow, December 12. The funds blocked in your bank account will be released. This is automatic.
2. Watch the Listing Day: The stock lists on December 15. Often, pre-listing hype cools down a few weeks after the IPO. If you believe in the long-term story, wait for a dip to enter.
3. Don’t Chase High Valuations: If the stock opens 30-40% higher, the valuation might become stretched. Exercise caution and consult a financial advisor.

For the Lucky Few: If you received an allotment, you have a decision to make on December 15. Do you book the ~28% listing gain, or do you hold for the long term? Historical data on similar pharma IPOs suggests that holding can be profitable, but locking in partial profits is a common strategy.

Frequently Asked Questions (FAQs)

In conclusion, the Corona Remedies IPO allotment status day marks a pivotal moment for the markets this week. Whether you are checking the Bigshare ipo status from an office in Mumbai or tracking the trends from a desk in Chicago, the overwhelming response to this IPO underscores the vitality of the healthcare sector.

For those who secured an allotment: Congratulations, you are holding a coveted asset. For those who didn’t: The market is full of opportunities, and capital preservation is just as important as capital appreciation. Keep your eyes on the listing day, December 15, as the real price discovery begins then.

The financial world never sleeps, and neither does the hunt for the next big opportunity.

For more breaking U.S. and Worldwide news, visit NH Punjab Breaking News daily.